On May 21, 2025, GSK plc purchased 567,590 shares at prices ranging from £1,417.50 to £1,434.00 each, as part of its ongoing buyback program, totaling 44,877,620 shares bought since February 24, 2025. The total number of shares in issue now stands at 4,101,310,936, excluding treasury shares.